MedTrace Logo

Artificial Intelligence (AI) Support in Medical Emergency Calls

NCT04648449 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-09-22

No results posted yet for this study

Summary

More than 12.000 patients suffer acute stroke in Norway every year, but less than half of them reach hospital within the current treatment window for thrombolysis. Stroke is the third-highest cause of death and the number one cause of severe disability requiring long time care at institutions. Consequently this has a high impact on society, patients and relatives, in addition to high costs related to care estimated to approximately 10 billion NOK per year. Although there are few studies on emergency medical communication centres (EMCC) in Norway, some have shown that the performance of the emergency medical communication centres can be improved. This project will seek to amend EMCC´s handling of acute stroke inquiries using artificial intelligence (AI), thus contributing to getting the patient to hospital in time for optimal treatments.

Conditions

  • Stroke, Acute
  • Apoplexy; Brain
  • Emergencies
  • Communication, Multidisciplinary

Interventions

OTHER

Artificial intelligence on emergency calls

AI listens to all calls to Bergen EMCC, detecting calls regarding possible stroke.

Sponsors & Collaborators

  • Helse Vest

    collaborator OTHER

  • Western Norway University of Applied Sciences

    collaborator OTHER

  • Oslo University Hospital

    collaborator OTHER

  • The Norwegian Heart and Lung Patient Organization

    collaborator UNKNOWN

  • Helsetjenestens driftsorganisasjon for nødnett HF (HDO)

    collaborator UNKNOWN

  • The Norwegian Stroke Register

    collaborator UNKNOWN

  • Haukeland University Hospital

    lead OTHER

Principal Investigators

  • Guttorm Brattebo, Professor II · Haukeland University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04648449 on ClinicalTrials.gov